Sheila C Dollard1, John D Roback, Clifford Gunthel, Minal M Amin, Sheilagh Barclay, Ericka Patrick, Matthew J Kuehnert. 1. Centers for Disease Control and Prevention, Atlanta, Georgia; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia; HIV/AIDS Clinical Trials Unit, Emory University School of Medicine, Atlanta, Georgia.
Abstract
BACKGROUND: Human herpesvirus 8 (HHV-8) is likely transmitted through blood transfusion in high-prevalence areas. The efficacy of leukoreduction filtration for reducing HHV-8 in blood has not been reported. STUDY DESIGN AND METHODS: Blood was drawn from 45 human immunodeficiency virus-positive men either with Kaposi's sarcoma (KS; n=21) or without KS (n=24) and subject to leukoreduction filtration. HHV-8 viral load was measured in plasma and in blood before and after filtration. RESULTS: Twelve subjects, all with KS, had detectable HHV-8 viremia before filtration with viral loads of 10(2) to 10(5) copies/mL (mean, 3 × 10(4) copies/mL). After filtration, seven of 12 subjects no longer had detectable HHV-8 in their blood, and five of 12 subjects had detectable HHV-8 that was 90% reduced on average from prefiltration levels. The presence of HHV-8 in the blood after filtration was strongly associated with prefiltration viral loads greater than 1000 copies/mL and the presence of cell-free virus in plasma. None of the subjects without KS had detectable levels of HHV-8 virus in blood before or after filtration. CONCLUSION: Cell-associated HHV-8 appeared to be effectively removed by leukoreduction filtration. Cell-free HHV-8 was present in 42% of subjects as 1% to 20% of the total virus which was not removed by filtration. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Human herpesvirus 8 (HHV-8) is likely transmitted through blood transfusion in high-prevalence areas. The efficacy of leukoreduction filtration for reducing HHV-8 in blood has not been reported. STUDY DESIGN AND METHODS: Blood was drawn from 45 human immunodeficiency virus-positive men either with Kaposi's sarcoma (KS; n=21) or without KS (n=24) and subject to leukoreduction filtration. HHV-8 viral load was measured in plasma and in blood before and after filtration. RESULTS: Twelve subjects, all with KS, had detectable HHV-8 viremia before filtration with viral loads of 10(2) to 10(5) copies/mL (mean, 3 × 10(4) copies/mL). After filtration, seven of 12 subjects no longer had detectable HHV-8 in their blood, and five of 12 subjects had detectable HHV-8 that was 90% reduced on average from prefiltration levels. The presence of HHV-8 in the blood after filtration was strongly associated with prefiltration viral loads greater than 1000 copies/mL and the presence of cell-free virus in plasma. None of the subjects without KS had detectable levels of HHV-8 virus in blood before or after filtration. CONCLUSION: Cell-associated HHV-8 appeared to be effectively removed by leukoreduction filtration. Cell-free HHV-8 was present in 42% of subjects as 1% to 20% of the total virus which was not removed by filtration. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Sheila C Dollard; Kenrad E Nelson; Paul M Ness; Veronica Stambolis; Matthew J Kuehnert; Philip E Pellett; Michael J Cannon Journal: Transfusion Date: 2005-04 Impact factor: 3.157
Authors: Wolfgang Hladik; Sheila C Dollard; Jonathan Mermin; Ashley L Fowlkes; Robert Downing; Minal M Amin; Flora Banage; Esau Nzaro; Peter Kataaha; Timothy J Dondero; Philip E Pellett; Eve M Lackritz Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245
Authors: P E Pellett; D J Wright; E A Engels; D V Ablashi; S C Dollard; B Forghani; S A Glynn; J J Goedert; F J Jenkins; T-H Lee; F Neipel; D S Todd; D Whitby; G J Nemo; M P Busch Journal: Transfusion Date: 2003-09 Impact factor: 3.157
Authors: Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett Journal: J Virol Date: 2004-11 Impact factor: 5.103
Authors: A Scott Laney; Michael J Cannon; Harold W Jaffe; Margaret K Offermann; Chin-Yih Ou; Kay W Radford; Mitesh M Patel; Thomas J Spira; Clifford J Gunthel; Philip E Pellett; Sheila C Dollard Journal: AIDS Date: 2007-07-31 Impact factor: 4.177
Authors: Sophie Voruz; Peter Gowland; Claudia Eyer; Nadja Widmer; Mélanie Abonnenc; Michel Prudent; Stavroula Masouridi-Levrat; Michel A Duchosal; Christoph Niederhauser Journal: Blood Transfus Date: 2020-02-28 Impact factor: 3.443
Authors: Sheila C Dollard; Pallavi Annambhotla; Phili Wong; Katherine Meneses; Minal M Amin; Ricardo M La Hoz; Erika D Lease; Maria Budev; Andrea Valeria Arrossi; Sridhar V Basavaraju; Christie P Thomas Journal: Am J Transplant Date: 2020-08-04 Impact factor: 8.086